Get ten ignores and you're limited to 3 posts a day. Twenty ignores and you're limited to one post a day. I'm liking that idea more and more. Hat tip to whoever pitched that one originally. Maui, remember how I predicted that a certain someone here would be having another dilution revenue feet to the fire meltdown right around March/April? Well, I may be a few days off but how bout that?! Hehe
More hot air expected with a chance of small molecules.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Hexcel Corporation Set for Upcoming Earnings Release
Hexcel Corporation (NYSE: HXL) is preparing to announce its earnings for the third quarter soon, capturing the attention of investors and analysts alike.
Anticipated Earnings Overview
The expectations for Hexcel's quarterly earnings stand at 46 cents per share, showing a solid increase from the 38 cents reported during the same period last year. Revenue projections for this quarter are set at appro... Continue Reading
Inclined: A New Chapter for Data Excellence
A new brand and expanded expertise for today's data-rich world.
Inclined, formerly known as FU Associates, Ltd., has evolved to better meet the demands of modern analytics and technology services. This rebranding marks an exciting shift for the firm, established in 1981, enhancing its commitment to providing innovative solutions that help government agencies operate more efficiently and effectively.
The foundation of Inclined ... Continue Reading
Essential Habits for a Strong Immune SystemAs we enter the cold and flu season, it's important to focus on maintaining a healthy immune system. Although it’s impossible to completely avoid germs, adopting certain habits can provide extra protection and help your body function at its best. Here are some effective strategies to support your immune health naturally.Commit to a Nutrient-Rich DietOne of the most effective ways to boost your immune system is to embrace a wh... Continue Reading
New Marketing Initiatives from Cruise Planners
Cruise Planners, the nation's largest home-based travel agency franchise network, has announced a transformative set of innovative marketing initiatives designed to inspire fresh travel experiences during its annual convention. These new initiatives demonstrate the company's unwavering commitment to equipping its advisors with top-notch marketing tools aimed at enhancing client engagement.
Empowering Advisors with Personalized M... Continue Reading
Carnegie Mellon University Introduces Advanced AI Program
Carnegie Mellon University, renowned as a leader in artificial intelligence education, has rolled out a new educational offering: a Master of Science in Artificial Intelligence Systems Management (AIM) program. This program is situated within the esteemed Heinz College of Information Systems and Public Policy. The move reflects the university's commitment to addressing the pressing demand for skilled professionals equipped to ... Continue Reading
NewAmsterdam Pharma Shows Promise with Obicetrapib
Piper Sandler has reiterated its Overweight rating and a price target of $37.00 for NewAmsterdam Pharma Co NV (NASDAQ: NAMS). This consistent outlook from the firm stems from a growing confidence in the company's drug, obicetrapib, especially as the Phase 3 BROADWAY trial is set to launch in the near future.
Drug Effectiveness and Clinical Trials
Recent discussions by NewAmsterdam Pharma management have illuminated t... Continue Reading
CMS Energy's Quarterly Dividend Declaration
The Board of Directors of CMS Energy has officially declared a quarterly dividend on the company’s common stock, a decision that reflects the company’s commitment to returning value to its shareholders.
Details of the Dividend Announcement
The dividend for the common stock (CUSIP: 125896100) is set at 51.50 cents per share. Shareholders of record will receive this payment on November 27, 2024, providing a timely benefit for ... Continue Reading
Boston Scientific's Growth Trajectory Post Acquisition
Boston Scientific (NYSE: BSX) has captured significant market attention following the acquisition of Silk Road Medical (NASDAQ: SILK). With Canaccord Genuity elevating Boston Scientific's price target from $88 to $98, this move reflects a growing confidence in the company's strategic direction. The deal, valued at approximately $1.18 billion, serves as a catalyst for Boston Scientific as it drives expansion in the medical technol... Continue Reading
J.P. Morgan's Capital Market Assumptions for 2025
J.P. Morgan Asset Management has recently unveiled its 2025 Long-Term Capital Market Assumptions (LTCMAs), providing valuable insights into the anticipated returns and risks across various asset classes for the next decade. These projections serve as a compass for investment strategies, targeting institutional and high-net-worth clients amid changing economic environments.
Projected Returns for 60/40 Portfolios
Accordi... Continue Reading
Sony Electronics and Cloud9 Join Forces for Gaming InnovationIn an exciting development within the esports sphere, Sony Electronics Inc. has announced a groundbreaking partnership with Cloud9, a prominent name in the esports community. This collaboration aims to enhance the gaming experience for Cloud9's elite Call of Duty team by providing them with state-of-the-art technology.Empowering Call of Duty Players with Advanced TechnologyThe partnership marks a significant... Continue Reading